Previous close | 243.27 |
Open | 243.57 |
Bid | 229.28 x 100 |
Ask | 229.65 x 200 |
Day's range | 229.14 - 243.57 |
52-week range | 204.44 - 261.54 |
Volume | |
Avg. volume | 420,591 |
Market cap | 10.81B |
Beta (5Y monthly) | 0.52 |
PE ratio (TTM) | 11.60 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Martine Rothblatt, Chairperson and Chief Executive Officer of United Therapeutics Corp (NASDAQ:UTHR), sold 30,000 shares of the company on March 26, 2024, according to a recent SEC Filing.
A closer look at one of the leaders in the pulmonary arterial hypertension treatment market